Congress designates bird flu research as agricultural priority
H.R. 2868 — SAVE Our Poultry Act · Filed by Sarah McBride (D-DE) · 4 cosponsors · Introduced Apr 10, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill adds highly pathogenic avian influenza (HPAI) to the list of high-priority research areas under federal agricultural law, authorizing grants to land-grant universities to study vaccine development for poultry and improve biosecurity practices on farms. The bill does not appropriate new money—it designates HPAI as eligible for existing research and extension funding streams.
Why we flagged it
The bill's sole operative function is to designate HPAI as a high-priority research area eligible for existing federal agricultural research grants. It is a straightforward public-health measure, not a subsidy, carve-out, or deregulation.
What the text implies
- The bill does not appropriate new funds—it relies on existing research budgets. Actual funding depends on congressional appropriations and agency prioritization; the bill creates eligibility but not guaranteed resources.
- Vaccine research and biosecurity improvements may reduce HPAI mortality in flocks, potentially lowering feed costs and stabilizing poultry prices for consumers, though market effects depend on adoption rates and disease prevalence.
The full analysis lists 3 implications of this text.
Who stands to gain
land-grant universities (research institutions); poultry producers (biosecurity training and tools); agricultural research contractors